Premium
ACE inhibitors: their propertiesand current role in hypertension
Author(s) -
Ooi SzeYuan,
Ball Stephen
Publication year - 2009
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.538
Subject(s) - medicine , medical prescription , first line , intensive care medicine , pharmacology
Abstract ACE inhibitors remain the first‐line choice of treatment of hypertension in patients under 55 years, and second line in other patient groups. Our Drug Review considers their properties and the latest evidence for their use in hypertension, followed by further sources of information and an analysis of prescription data. Copyright © 2009 Wiley Interface Ltd.